Xeljanz XR 11 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F1AC8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $51,729
Award facts
- Contract value 100% obligated
- $51,729.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $51.7K firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30-count bottles of Xeljanz XR 11 mg tablets on January 16, 2026, with a completion date of January 20, 2026. The award was made on a competitive basis with no set-aside designation. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.99M through December 2031. The product will be distributed from AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania.
Xeljanz XR is a prescription immunosuppressant medication used to treat rheumatoid arthritis and other inflammatory conditions. This delivery order represents routine pharmaceutical procurement under DLA's medical supply chain operations, which distribute critical medications to military treatment facilities, veterans' healthcare programs, and other federal medical institutions. AmerisourceBergen, as a major pharmaceutical distributor and healthcare solutions provider, serves as a key vendor fulfilling the Defense Health Agency's pharmaceutical requirements through its comprehensive IDC vehicle.
Quick answers
Who was awarded contract SPE2DR26F1AC8?
SPE2DR26F1AC8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26F1AC8 worth?
The government has obligated $51,729 on SPE2DR26F1AC8.
Is contract SPE2DR26F1AC8 an order under another contract?
Yes. SPE2DR26F1AC8 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F1AC8 competed?
The extent of competition for SPE2DR26F1AC8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award